Bicycle Therapeutics Statistics
Total Valuation
BCYC has a market cap or net worth of $302.53 million. The enterprise value is -$308.73 million.
Important Dates
The last earnings date was Tuesday, March 17, 2026, before market open.
| Earnings Date | Mar 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BCYC has 69.71 million shares outstanding. The number of shares has increased by 19.02% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 69.71M |
| Shares Change (YoY) | +19.02% |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | 1.68% |
| Owned by Institutions (%) | 39.18% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.17 |
| Forward PS | 10.92 |
| PB Ratio | 0.49 |
| P/TBV Ratio | 0.50 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.98, with a Debt / Equity ratio of 0.03.
| Current Ratio | 11.98 |
| Quick Ratio | 11.65 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,178.96 |
Financial Efficiency
Return on equity (ROE) is -31.21% and return on invested capital (ROIC) is -21.24%.
| Return on Equity (ROE) | -31.21% |
| Return on Assets (ROA) | -18.13% |
| Return on Invested Capital (ROIC) | -21.24% |
| Return on Capital Employed (ROCE) | -36.76% |
| Weighted Average Cost of Capital (WACC) | 12.48% |
| Revenue Per Employee | $237,987 |
| Profits Per Employee | -$717,902 |
| Employee Count | 305 |
| Asset Turnover | 0.09 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BCYC has paid $152,000 in taxes.
| Income Tax | 152,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -52.20% in the last 52 weeks. The beta is 1.61, so BCYC's price volatility has been higher than the market average.
| Beta (5Y) | 1.61 |
| 52-Week Price Change | -52.20% |
| 50-Day Moving Average | 5.77 |
| 200-Day Moving Average | 7.05 |
| Relative Strength Index (RSI) | 28.71 |
| Average Volume (20 Days) | 496,871 |
Short Selling Information
The latest short interest is 2.12 million, so 5.50% of the outstanding shares have been sold short.
| Short Interest | 2.12M |
| Short Previous Month | 2.14M |
| Short % of Shares Out | 5.50% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.90 |
Income Statement
In the last 12 months, BCYC had revenue of $72.59 million and -$218.96 million in losses. Loss per share was -$3.16.
| Revenue | 72.59M |
| Gross Profit | -156.50M |
| Operating Income | -242.87M |
| Pretax Income | -218.81M |
| Net Income | -218.96M |
| EBITDA | -236.44M |
| EBIT | -242.87M |
| Loss Per Share | -$3.16 |
Full Income StatementBalance Sheet
The company has $628.11 million in cash and $16.85 million in debt, with a net cash position of $611.26 million or $8.77 per share.
| Cash & Cash Equivalents | 628.11M |
| Total Debt | 16.85M |
| Net Cash | 611.26M |
| Net Cash Per Share | $8.77 |
| Equity (Book Value) | 609.98M |
| Book Value Per Share | 8.79 |
| Working Capital | 625.90M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$249.68 million and capital expenditures -$2.35 million, giving a free cash flow of -$252.03 million.
| Operating Cash Flow | -249.68M |
| Capital Expenditures | -2.35M |
| Depreciation & Amortization | 6.42M |
| Net Borrowing | -168,000 |
| Free Cash Flow | -252.03M |
| FCF Per Share | -$3.62 |
Full Cash Flow StatementMargins
| Gross Margin | -215.60% |
| Operating Margin | -334.59% |
| Pretax Margin | -301.45% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BCYC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.02% |
| Shareholder Yield | -19.02% |
| Earnings Yield | -72.38% |
| FCF Yield | -83.31% |
Analyst Forecast
The average price target for BCYC is $14.00, which is 222.58% higher than the current price. The consensus rating is "Buy".
| Price Target | $14.00 |
| Price Target Difference | 222.58% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 51.51% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BCYC has an Altman Z-Score of 1.6 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.6 |
| Piotroski F-Score | 2 |
